| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/25/2004 | US20040058905 FKBP inhibitors |
| 03/25/2004 | US20040058904 Antiinflammatory agents; autoimmune disease |
| 03/25/2004 | US20040058903 Anticholesterol agents; cardiovascular disorders |
| 03/25/2004 | US20040058900 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 03/25/2004 | US20040058899 Use of epothilones and analogs in conjunction with ophthalmic surgery |
| 03/25/2004 | US20040058898 Pharmaceutical composition for alleviating the violence of a mammal comprising nortestosterone derivatives |
| 03/25/2004 | US20040058897 Estrogenic substances combined with cruciferous indole compounds |
| 03/25/2004 | US20040058896 Uniform dispersion in excipient of fatty acid, triglyceride and,or fatty ester |
| 03/25/2004 | US20040058895 Administering by injection; reduction of blood parathyroid hormone |
| 03/25/2004 | US20040058894 Immunosuppression; lymphocyte sequestering; autoimmune diseases; antiinflammatory agents |
| 03/25/2004 | US20040058893 Sexual disorders, aids, hepatitis virus |
| 03/25/2004 | US20040058892 Antidiabetic agents |
| 03/25/2004 | US20040058890 Replacement fir carbohydrates, fats; dietetics; therapy for non-insulin dependent diabetes |
| 03/25/2004 | US20040058889 Use of beta glucans for the treatment of osteoporosis and other diseases of bone resorption |
| 03/25/2004 | US20040058888 Immobilized on solid support; therapy for organ rejection, infections |
| 03/25/2004 | US20040058884 Detecting diseases by Selex method; anticancer agents |
| 03/25/2004 | US20040058883 Oligonucleotide compositions and their use for the modulation of immune responses |
| 03/25/2004 | US20040058880 Bactericides; therapy for infections; anticancer agents |
| 03/25/2004 | US20040058879 Processes for preparing clarithromycin polymorphs and novel polymorph IV |
| 03/25/2004 | US20040058876 Secondary binding site of dipeptidyl peptidase IV (DP IV) |
| 03/25/2004 | US20040058875 Prevent cytokine biosynthesis; topical applying to eye |
| 03/25/2004 | US20040058873 Method for treating or preventing Alzheimer's disease |
| 03/25/2004 | US20040058858 Configuration of glycosaminoglycans |
| 03/25/2004 | US20040058857 Mixture of glucocorticoids and prostate specific antigen, or complex thereof; anticancer agents |
| 03/25/2004 | US20040058855 Use of materials having zinc ionophoric behavior |
| 03/25/2004 | US20040058854 Synergistc therapy; bioavailability |
| 03/25/2004 | US20040058853 Multivalent neuraminidase inhibitor conjugates |
| 03/25/2004 | US20040058852 Antihypoxic agents; antiischemic agents ; anticonvulsants; infant therapy |
| 03/25/2004 | US20040058850 Using caspase inhibitor; antiinflammatory agents |
| 03/25/2004 | US20040058820 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis |
| 03/25/2004 | US20040058592 Reduction inhibitory agent for active-oxygen eliminating activity |
| 03/25/2004 | US20040058448 Transgenic gram negative bacteria for production of oligo and/or polysaccharides; gene therapy and vaccine development |
| 03/25/2004 | US20040058444 Bioprosthetic heart valves |
| 03/25/2004 | US20040058443 Manipulation of non-terminally differentiated cells using the Notch pathway |
| 03/25/2004 | US20040058367 Comprises interleukin 1b converting enzyme inhibitor for diagnosis, prevention and treatment of viral, nervous system, ischemic and graft-versus-host diseases |
| 03/25/2004 | US20040058321 Comprises nucleotide sequences coding transforming growth factor binding proteins for diagnosis and treatment of osteoporosis and osteopenia |
| 03/25/2004 | US20040058313 Using gabapentim to relieve external pressure and improve glaucoma treatments; neuroprotectants and eye surgery; neurotoxins and vision defects |
| 03/25/2004 | US20040058309 Blood composition for use in bioartificial liver for in vitro detoxification and treatment of hepatocyte disfunction |
| 03/25/2004 | US20040058025 Digestive/laxative compositions |
| 03/25/2004 | US20040058024 Comprises polyunsaturated fatty acid-containing composition extracted from Echium plants, with antilipemic agents, antioxidants, and antidiabetic agents, for formulation as dietary supplement |
| 03/25/2004 | US20040058022 Method for producing fat and /or solids from beans and compositions containing polyphenols |
| 03/25/2004 | US20040058021 Which suppresses I-kappa-B-alpha phosphorylation through inhibition kinase activity and downregulating NF-kappa-B; antiproliferative agents |
| 03/25/2004 | US20040058019 Kit and method for migraine headache treatment |
| 03/25/2004 | US20040058018 Novel substituted benzimidazole dosage forms and method of using same |
| 03/25/2004 | US20040058016 Lower alcohol-insoluble extract of hovenia dulcis var koreana nakai, a polysaccharide isolated therefrom and an antihepatotoxic composition containing same |
| 03/25/2004 | US20040058015 Nutraceuticals; for combination with herbs |
| 03/25/2004 | US20040058009 Nanoparticulate fibrate formulations |
| 03/25/2004 | US20040058008 For reducing aggregation; encapsulated by polyanhydrides |
| 03/25/2004 | US20040058007 Such as proteins or polypeptides via anti-solvent under supercritical conditions; water solubility |
| 03/25/2004 | US20040058005 Comprises polyvinylpyrrolidone; for improved bioavailability/ dissolution |
| 03/25/2004 | US20040058004 Suspensions of micronized fenofibrate |
| 03/25/2004 | US20040058002 Expandable osmotic composition and coating suspension |
| 03/25/2004 | US20040058001 For controlled release; drug delivery |
| 03/25/2004 | US20040058000 Controlled release capsule for delivery of liquid formulation |
| 03/25/2004 | US20040057999 Fenofibrate compositions having enhanced bioavailability |
| 03/25/2004 | US20040057998 Granulates of micronized fenofibrate; high bioavailability through improved dissolution |
| 03/25/2004 | US20040057997 Capsules containing fenofibrate compositions |
| 03/25/2004 | US20040057994 Combination of acetyl L-carnitine and propionyl L-carnitine or their salts; treating nephropathies due to nephrotoxic drugs or environmental contaminants |
| 03/25/2004 | US20040057992 6-phenyl-5-(4-(2-pyrrolidin-1-ylethoxy)phenyl)-5,6,7,8 -tetrahydronaphthalen-2-ol (laxofoxifene); a prodrug with a glidant, disintegrant, lubricant and diluent/filler in given amounts; unit dosage forms, including low dosage forms |
| 03/25/2004 | US20040057990 Liposomal benzoquinazoline thymidylate synthase inhibitor formulations |
| 03/25/2004 | US20040057989 Method of cancer treatment |
| 03/25/2004 | US20040057987 With a permeation enhancer or mixture such as myristyl sarcosine; treatment of acute renal failure |
| 03/25/2004 | US20040057985 With sufficient release rates without needing any enhancer; oxybutynin of the droplet-shaped inner phase will not accumulate at the interfaces and surfaces of the matrix layer if certain polymers are used as pressure sensitive adhesive |
| 03/25/2004 | US20040057981 Gelled delivery vehicle containing nutritional ingredients |
| 03/25/2004 | US20040057980 Procedure and composition of treatment and/or care of the eye |
| 03/25/2004 | US20040057979 Methods for treating inflammation-mediated conditions of the eye |
| 03/25/2004 | US20040057972 By adjusting the pH of the composition to between 6.5 and about 8.1 |
| 03/25/2004 | US20040057967 Generation of virus-like particles and demonstration of lipid rafts as sites of filovirus entry and budding |
| 03/25/2004 | US20040057964 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants |
| 03/25/2004 | US20040057955 Methods of inhibition of stenosis and/or sclerosis of the aortic valve |
| 03/25/2004 | US20040057949 Hemodialysis method for improving immune system function |
| 03/25/2004 | US20040057929 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells |
| 03/25/2004 | US20040057926 Administering inhibitor of arginase I, an inhibitor of a cationic amino acid transporter Y+ receptor or a liposomal formulation of arginine or an arginine provider to a mammal wherein an immune response in mammal is increased |
| 03/25/2004 | US20040057917 Strengthens the pigment formation in the skin |
| 03/25/2004 | US20040057906 Perfluorocarbon emulsions with non-fluorinated surfactants |
| 03/25/2004 | US20040057905 Nanoparticulate beclomethasone dipropionate compositions |
| 03/25/2004 | US20040056372 Stabilizing a high concentrate drug content in water, by dissolving the drug and a polyetheramide copolymer in solvent, forming water in oil emulsion, volatilizing, desolventizing, supersonic treatment and ultrafiltration |
| 03/25/2004 | US20040055609 Treatment of hepatitis C using hyperthermia |
| 03/25/2004 | DE10237057A1 Transdermal therapeutic systems containing buprenorphine, useful in treating pain or urinary incontinence, also containing mu-, kappa- or delta-opioid receptor antagonist to reduce abuse potential |
| 03/25/2004 | DE10111682B4 Caloporosid-Derivate, Verfahren zu deren Herstellung und deren Verwendung Caloporoside derivatives, processes for their preparation and their use |
| 03/25/2004 | CA2799437A1 Method of producing hydroxyalkyl starch derivatives |
| 03/25/2004 | CA2532912A1 Full range nutritional supplements from plant materials and methods for their manufacture |
| 03/25/2004 | CA2499142A1 Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia |
| 03/25/2004 | CA2499136A1 Accelerating recovery from trauma |
| 03/25/2004 | CA2499075A1 Production of bispecific molecules using polyethylene glycol linkers |
| 03/25/2004 | CA2498930A1 Modified release oral dosage form |
| 03/25/2004 | CA2498911A1 Tiotropium salts for reducing respiratory mortality rate |
| 03/25/2004 | CA2498777A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | CA2498655A1 2-amino-4-quinazolinones as lxr nuclear receptor binding compounds |
| 03/25/2004 | CA2498581A1 Thioredoxin composition and uses thereof for liquefaction of mucus or sputum |
| 03/25/2004 | CA2498532A1 Antidepressant piperidine derivatives of heterocycle-fused benzodioxans |
| 03/25/2004 | CA2498495A1 Phenyl-aza-benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
| 03/25/2004 | CA2498493A1 Phenyl-indole compounds |
| 03/25/2004 | CA2498410A1 Capsules containing aqueous fill compositions stabilized with derivatized cyclodextrin |
| 03/25/2004 | CA2498399A1 Method of treating diabetes and related conditions |
| 03/25/2004 | CA2498269A1 Substituted aminoethers for the treatment of alzheimer's disease |
| 03/25/2004 | CA2498260A1 Pharmaceutical formulations of modafinil |
| 03/25/2004 | CA2498248A1 Acetyl 2-hydroxy-1,3 diaminoalkanes |
| 03/25/2004 | CA2498237A1 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators |
| 03/25/2004 | CA2498175A1 Treatment of cns disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine |